Publication | Closed Access

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells

Transcriptional ActivationAzelaic Bishydroxamic AcidChemoprevention StrategyBiochemistryOncogenic AgentMedicineMelanomaTumor SelectivityAnti-cancer AgentCancer BiologyCell BiologyCancer ResearchTumor MicroenvironmentTumor Biology